Quent Long Short Global Small Cap Fund’s Vertex Pharmaceuticals VRTX Stock Holding History

Quent Long Short Global Small Cap Fund’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$253K	Buy	+557	New	+$240K	0.02%	256

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Quent Long Short Global Small Cap Fund's VRTX Position: Q4 2025 in Review

Quent Long Short Global Small Cap Fund opened a new position in Vertex Pharmaceuticals (VRTX) in Q4 2025: 557 shares worth $253K. The stake represents 0.02% of the portfolio and ranks #256 among its holdings.

1,670 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.

Quent Long Short Global Small Cap Fund held 557 shares of Vertex Pharmaceuticals worth $253K as of Q4 2025.
Vertex Pharmaceuticals was a new Quent Long Short Global Small Cap Fund position in Q4 2025.
Vertex Pharmaceuticals made up 0.02% of Quent Long Short Global Small Cap Fund's portfolio in Q4 2025, its #256 holding.
1,670 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.

Based on Quent Long Short Global Small Cap Fund's 13F filing for Q4 2025, filed 28 Jan 2026.